National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect, 57583 [E7-19887]
Download as PDF
Federal Register / Vol. 72, No. 195 / Wednesday, October 10, 2007 / Notices
57583
Dated: October 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–19887 Filed 10–9–07; 8:45 am]
Dated: October 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–19879 Filed 10–9–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Time and Date: 12 p.m.–2 p.m., October
24, 2007.
Place: The conference call will originate at
the National Center on Birth Defects and
Developmental Disabilities (NCBDDD), in
Atlanta, Georgia. Please see Supplementary
Information for details on accessing the
conference call.
Status: Open to the public, limited only by
the availability of telephone ports.
Purpose: The Secretary is authorized by the
Public Health Service Act, Section 399G, (42
U.S.C. Section 280f, as added by Pub. L. 105–
392) to establish a National Task Force on
Fetal Alcohol Syndrome and Fetal Alcohol
Effect to: (1) Foster coordination among all
governmental agencies, academic bodies and
community groups that conduct or support
Fetal Alcohol Syndrome (FAS) and Fetal
Alcohol Effect (FAE) research, programs and
surveillance; and (2) to otherwise meet the
general needs of populations actually or
potentially impacted by FAS and FAE.
Matters to be Discussed: The Task Force
will convene via conference call to: (1)
Discuss and vote on the Task Force report,
‘‘Reducing Alcohol-Exposed Pregnancies,’’
(2) provide an update on approved Task
Force document, ‘‘Call to Action: Ensuring
Research and Essential Services for Persons
with FASDs and their Caregivers’’, and (3)
discuss plans for disseminating final Task
Force products.
Agenda items are subject to change as
priorities dictate.
Supplementary Information: This
conference call is scheduled to begin on
October 24, 2007 at 12 p.m., Eastern Standard
Time. To participate in the conference call,
please dial 1 (866) 619–1481 and enter
conference passcode 4832402. You will then
be automatically connected to the call.
Contact Person for More Information: Mary
Kate Weber, M.P.H., Designated Federal
Officer, NBDDD, CDC, 1600 Clifton Road,
NE., Mailstop E–86, Atlanta, Georgia 30333.
Telephone (404) 498–3926, Fax (404) 498–
3550.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
Health Resources and Services
Administration (HRSA); CDC/HRSA
Advisory Committee on HIV and STD
Prevention and Treatment
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rwilkins on PROD1PC63 with NOTICES
National Task Force on Fetal Alcohol
Syndrome and Fetal Alcohol Effect
VerDate Aug<31>2005
17:08 Oct 09, 2007
Jkt 214001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–5 p.m., November 15, 2007.
8 a.m.–12:15 p.m., November 16, 2007.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, Maryland,
Telephone (301) 652–2000, Fax (301) 664–
7317.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
Purpose: This Committee is charged with
advising the Director, CDC and the
Administrator, HRSA, regarding activities
related to prevention and control of HIV/
AIDS and other STDs, the support of health
care services to persons living with HIV/
AIDS, and education of health professionals
and the public about HIV/AIDS and other
STDs.
Matters to be Discussed: Agenda items
include issues pertaining to (1)
Implementation of the Ryan White HIV/AIDS
Treatment Modernization Act of 2006; (2)
HIV and STD Prevention and Treatment in
Program Targeted to Native Americans,
Alaska Natives, and Native Hawaiians; and
the (3) Efforts to Integrate and Promote HIV/
STD Prevention and Management Strategies.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Committee Management
Specialist, CDC, Strategic Business Unit,
1600 Clifton Road, NE., Mailstop E–07,
Atlanta, Georgia 30333. Telephone (404)
639–8317, Fax (404) 639–8910, E-mail
zkr7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
National Institute for Occupational
Safety and Health (NIOSH), Safety and
Occupational Health Study Section
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates:
8 a.m.–5 p.m., October 25, 2007.
8 a.m.–5 p.m., October 26, 2007.
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia, 22314.
Telephone (703) 684.5900, Fax (703)
684.1403.
Purpose: The Safety and Occupational
Health Study Section will review, discuss,
and evaluate grant application(s) received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services, and the
prevention of work-related injury and illness.
It is anticipated that research funded will
promote these program goals.
Matters to be Discussed: The meeting will
convene to address matters related to the
conduct of Study Section business and for
the study section to consider safety and
occupational health-related grant
applications. These portions of the meeting
will be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, Centers for
Disease Control and Prevention, pursuant to
Section 10(d) Pub. L. 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Price
Connor, PhD, NIOSH Health Scientist, 1600
Clifton Road, NE., Mailstop E–20, Atlanta,
Georgia 30333. Telephone (404) 498.2511,
Fax (404) 498.2571.
The Director, Management Analysis and
Services Office, has been delegated the
E:\FR\FM\10OCN1.SGM
10OCN1
Agencies
[Federal Register Volume 72, Number 195 (Wednesday, October 10, 2007)]
[Notices]
[Page 57583]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-19887]
[[Page 57583]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol
Effect
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 12 p.m.-2 p.m., October 24, 2007.
Place: The conference call will originate at the National Center
on Birth Defects and Developmental Disabilities (NCBDDD), in
Atlanta, Georgia. Please see Supplementary Information for details
on accessing the conference call.
Status: Open to the public, limited only by the availability of
telephone ports.
Purpose: The Secretary is authorized by the Public Health
Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Pub.
L. 105-392) to establish a National Task Force on Fetal Alcohol
Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among
all governmental agencies, academic bodies and community groups that
conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol
Effect (FAE) research, programs and surveillance; and (2) to
otherwise meet the general needs of populations actually or
potentially impacted by FAS and FAE.
Matters to be Discussed: The Task Force will convene via
conference call to: (1) Discuss and vote on the Task Force report,
``Reducing Alcohol-Exposed Pregnancies,'' (2) provide an update on
approved Task Force document, ``Call to Action: Ensuring Research
and Essential Services for Persons with FASDs and their
Caregivers'', and (3) discuss plans for disseminating final Task
Force products.
Agenda items are subject to change as priorities dictate.
Supplementary Information: This conference call is scheduled to
begin on October 24, 2007 at 12 p.m., Eastern Standard Time. To
participate in the conference call, please dial 1 (866) 619-1481 and
enter conference passcode 4832402. You will then be automatically
connected to the call.
Contact Person for More Information: Mary Kate Weber, M.P.H.,
Designated Federal Officer, NBDDD, CDC, 1600 Clifton Road, NE.,
Mailstop E-86, Atlanta, Georgia 30333. Telephone (404) 498-3926, Fax
(404) 498-3550.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the CDC and ATSDR.
Dated: October 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E7-19887 Filed 10-9-07; 8:45 am]
BILLING CODE 4163-18-P